Dr. Rick Furman Discusses COVID-19 and the Vaccines in Chronic Lymphocytic Leukemia (CLL) Patients, Live at the New York City CLL Society Support Group Meeting
Dr. Koffman on COVID-19 Vaccines
12/2020
There is promising news about COVID-19 vaccines, but does that news apply to those of us with CLL? The Moderna and Pfizer vaccines are made with a new technology that uses messenger or mRNA that teaches our cells to recognize SARS-CoV-2’s spike protein and thus prevent infection. The live Oxford/AstraZeneca vaccine is also a new type of vaccine, made from a virus that causes colds in chimpanzees and has been genetically modified not to replicate in humans and to carry into our immune cells the SARS-CoV-2’s spike protein that confers immunity. Dr. Koffman shares what we know, what we don’t know and next steps.
Related posts